1-3 of 3
Marcela Cavalcante de Andrade Silva, MD
Close
Sort by
Journal Articles

Would Be Cyclophosphamide, Thalidomide and Dexamethasone (CTD) a Possible Treatment For Multiple Myeloma Where Is Not Possible New Drugs?

Marcelo Bellesso, MD, Marcela Cavalcante de Andrade Silva, MD, Rodrigo Dolphini Velasques, MD, Helena Visnadi, MD, Roberta Shcolnik, MD, Fernanda Salles Seguro, MD, Debora Levy, Andre Neder Ramires Abdo, MD, Rodrigo Santucci, MD, Juliana Pereira, PhD, Gracia Aparecida Martinez, PhD
Journal: Blood
Blood (2013) 122 (21): 5385.
https://doi.org/10.1182/blood.V122.21.5385.5385
Published: 2013
Journal Articles

Clonal Dasatinib Large Granular Expansion Is Associated with Suboptimal and Optimal Leukemia Net Response Criteria in Chronic Myelogenous Leukemia

Flávia Dias Xavier, MD, Fernanda Salles Seguro, MD, Marcela Cavalcante de Andrade Silva, MD, Daniel Salas Steinbaum, MD, Mariana Serpa, MD, Gracia Aparecida Martinez, Carla Rosa Teixeira de Godoy, Graciela Aparecida Aparecida Brocardo, Lis Vilela de Almeida, Debora Levy, Fernanda Fava, Claudia Bitti Barroso, MD, Israel Bendit, MD, Juliana Pereira, PhD, Pedro E Dorlhiac Llacer, PhD
Journal: Blood
Blood (2011) 118 (21): 1696.
https://doi.org/10.1182/blood.V118.21.1696.1696
Published: 2011
Journal Articles

Non-Standard Doses of Dasatinib Sustain Cytogenetic Response In Chronic Myeloid Leukemia (CML) Patients

Fernanda Salles Seguro, MD, Mariana Gomes Serpa, MD, Marcela Cavalcante de Andrade Silva, MD, Daniel Salas Steinbaum, MD, Thales DM Pereira, MD, Flavia Dias Xavier, MD, Claudia Bitti Barroso, MD, Israel Bendit, MD, PhD, Pedro E Dorlhiac Llacer, PhD
Journal: Blood
Blood (2010) 116 (21): 2285.
https://doi.org/10.1182/blood.V116.21.2285.2285
Published: 2010